160 related articles for article (PubMed ID: 32987805)
1. 8p11.23 Amplification in Breast Cancer: Molecular Characteristics, Prognosis and Targeted Therapy.
Voutsadakis IA
J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32987805
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and Prognosis of 8p11.23-Amplified Squamous Lung Carcinomas.
Voutsadakis IA
J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902501
[TBL] [Abstract][Full Text] [Related]
3. Amplification of 8p11.23 in cancers and the role of amplicon genes.
Voutsadakis IA
Life Sci; 2021 Jan; 264():118729. PubMed ID: 33166592
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer.
Rutkovsky AC; Yeh ES; Guest ST; Findlay VJ; Muise-Helmericks RC; Armeson K; Ethier SP
BMC Cancer; 2019 May; 19(1):491. PubMed ID: 31122207
[TBL] [Abstract][Full Text] [Related]
5. Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon.
Streicher KL; Yang ZQ; Draghici S; Ethier SP
Oncogene; 2007 Mar; 26(14):2104-14. PubMed ID: 17001308
[TBL] [Abstract][Full Text] [Related]
6. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines.
Ray ME; Yang ZQ; Albertson D; Kleer CG; Washburn JG; Macoska JA; Ethier SP
Cancer Res; 2004 Jan; 64(1):40-7. PubMed ID: 14729606
[TBL] [Abstract][Full Text] [Related]
7. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.
Garcia MJ; Pole JC; Chin SF; Teschendorff A; Naderi A; Ozdag H; Vias M; Kranjac T; Subkhankulova T; Paish C; Ellis I; Brenton JD; Edwards PA; Caldas C
Oncogene; 2005 Aug; 24(33):5235-45. PubMed ID: 15897872
[TBL] [Abstract][Full Text] [Related]
8. Amplicons in breast cancers analyzed by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
Ooi A; Inokuchi M; Horike SI; Kawashima H; Ishikawa S; Ikeda H; Nakamura R; Oyama T; Dobashi Y
Hum Pathol; 2019 Mar; 85():33-43. PubMed ID: 30385370
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma.
Parris TZ; Rönnerman EW; Engqvist H; Biermann J; Truvé K; Nemes S; Forssell-Aronsson E; Solinas G; Kovács A; Karlsson P; Helou K
Oncotarget; 2018 May; 9(35):24140-24154. PubMed ID: 29844878
[TBL] [Abstract][Full Text] [Related]
10. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer.
Turner-Ivey B; Guest ST; Irish JC; Kappler CS; Garrett-Mayer E; Wilson RC; Ethier SP
Neoplasia; 2014 Aug; 16(8):644-55. PubMed ID: 25220592
[TBL] [Abstract][Full Text] [Related]
11. Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines.
Yang ZQ; Albertson D; Ethier SP
Cancer Genet Cytogenet; 2004 Nov; 155(1):57-62. PubMed ID: 15527903
[TBL] [Abstract][Full Text] [Related]
12. Genomic analysis of the 8p11-12 amplicon in familial breast cancer.
Melchor L; Garcia MJ; Honrado E; Pole JC; Alvarez S; Edwards PA; Caldas C; Brenton JD; Benítez J
Int J Cancer; 2007 Feb; 120(3):714-7. PubMed ID: 17096335
[TBL] [Abstract][Full Text] [Related]
13. An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast Tumors.
Luo J; Liu S; Leung S; Gru AA; Tao Y; Hoog J; Ho J; Davies SR; Allred DC; Salavaggione AL; Snider J; Mardis ER; Nielsen TO; Ellis MJ
J Mol Diagn; 2017 Jan; 19(1):147-161. PubMed ID: 27993329
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.
Bernard-Pierrot I; Gruel N; Stransky N; Vincent-Salomon A; Reyal F; Raynal V; Vallot C; Pierron G; Radvanyi F; Delattre O
Cancer Res; 2008 Sep; 68(17):7165-75. PubMed ID: 18757432
[TBL] [Abstract][Full Text] [Related]
15. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.
Brown LA; Irving J; Parker R; Kim H; Press JZ; Longacre TA; Chia S; Magliocco A; Makretsov N; Gilks B; Pollack J; Huntsman D
Gynecol Oncol; 2006 Feb; 100(2):264-70. PubMed ID: 16236351
[TBL] [Abstract][Full Text] [Related]
16. Clinical Impact of 11q13.3 Amplification on Immune Cell Infiltration and Prognosis in Breast Cancer.
Zhou R; Zhu X; Peng Y; Zhong L; Peng L; Yang B; Meng Y; Chen X; Lu Y
Int J Gen Med; 2022; 15():4037-4052. PubMed ID: 35444456
[TBL] [Abstract][Full Text] [Related]
17. Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon.
Rooney C; Geh C; Williams V; Heuckmann JM; Menon R; Schneider P; Al-Kadhimi K; Dymond M; Smith NR; Baker D; French T; Smith PD; Harrington EA; Barrett JC; Kilgour E
PLoS One; 2016; 11(2):e0149628. PubMed ID: 26905262
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive profiling of 8p11-12 amplification in breast cancer.
Gelsi-Boyer V; Orsetti B; Cervera N; Finetti P; Sircoulomb F; Rougé C; Lasorsa L; Letessier A; Ginestier C; Monville F; Esteyriès S; Adélaïde J; Esterni B; Henry C; Ethier SP; Bibeau F; Mozziconacci MJ; Charafe-Jauffret E; Jacquemier J; Bertucci F; Birnbaum D; Theillet C; Chaffanet M
Mol Cancer Res; 2005 Dec; 3(12):655-67. PubMed ID: 16380503
[TBL] [Abstract][Full Text] [Related]
19. Elevated NSD3 histone methylation activity drives squamous cell lung cancer.
Yuan G; Flores NM; Hausmann S; Lofgren SM; Kharchenko V; Angulo-Ibanez M; Sengupta D; Lu X; Czaban I; Azhibek D; Vicent S; Fischle W; Jaremko M; Fang B; Wistuba II; Chua KF; Roth JA; Minna JD; Shao NY; Jaremko Ł; Mazur PK; Gozani O
Nature; 2021 Feb; 590(7846):504-508. PubMed ID: 33536620
[TBL] [Abstract][Full Text] [Related]
20. Transforming properties of 8p11-12 amplified genes in human breast cancer.
Yang ZQ; Liu G; Bollig-Fischer A; Giroux CN; Ethier SP
Cancer Res; 2010 Nov; 70(21):8487-97. PubMed ID: 20940404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]